Postpartum hemorrhage (PPH) still remains one of the major causes of maternal mortality, accounting for 35% of all maternal deaths. The World Health Organization (WHO) has recommended oxytocin as the most effective medicine for the prevention and treatment of PPH, particularly for facility-based births. Most countries include oxytocin on their essential medicines lists (EML) as … Read more
Archive PPH
Access to and Quality of Maternal Health Medicines and Care
“Respectful maternal care was said to be more than just a means to an end, and can be framed as several issues: human rights, quality of care, equity and public health,” Jocalyn Clark, senior editor of PLoS Medicine, noted on the final day of the 2013 Global Maternal Health Conference (GMHC). Quality of care seems … Read more
Increasing Access to Life-saving Medicines for Maternal Health in South Sudan
Postpartum hemorrhage (PPH) is a major public health issue in South Sudan as recent estimates show a maternal mortality rate of 2,054 deaths per 100,000 live births. Compounded with an equally high infant mortality of 102 per 1,000 live births and under-five mortality of 135 per 1,000 live births, South Sudan’s maternal and child health … Read more